Catalyst defends drug price after Bernie Sanders' rebuke

Catalyst Pharmaceuticals Inc, targeted by U.S. Senator Bernie Sanders for high drug prices, said on Thursday that prices of its treatment for a rare neurological disorder were "in line" with similar products in the industry.

from Reuters: Health News https://ift.tt/2TemCAJ
via IFTTT